- Home
- FRSH vs AXSM Comparison
FRSH vs AXSM Comparison
Compare FRSH & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRSH | AXSM |
|---|---|---|
| Founded | 2010 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 7.4B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | FRSH | AXSM |
|---|---|---|
| Price | $12.30 | $153.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 20 |
| Target Price | $19.53 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 3.4M | 479.3K |
| Earning Date | 02-10-2026 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $810,640,000.00 | $561,263,000.00 |
| Revenue This Year | $18.20 | $66.40 |
| Revenue Next Year | $13.36 | $56.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 18.18 | ★ 65.83 |
| 52 Week Low | $10.51 | $75.56 |
| 52 Week High | $19.77 | $158.57 |
Technical Indicators
Market Signals| Indicator | FRSH | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 48.49 | 62.63 |
| Support Level | $12.11 | $152.41 |
| Resistance Level | $12.76 | $158.56 |
| Average True Range (ATR) | 0.40 | 4.21 |
| MACD | -0.09 | 0.15 |
| Stochastic Oscillator | 12.67 | 66.19 |
Price Performance
Historical ComparisonAbout FRSH Freshworks Inc.
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.